Rockford, MI, United States of America

Katie Renee Martin

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: The Translational Genomics Research Institute, Van Andel Research Institute. Active years: 2015-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katie Renee Martin. Retrieved from https://idiyas.com/inventor/katie-renee-martin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Minneapolis, MN (US) (2015)
  • Rockford, MI (US) (2020)

Company Filing History:


Years Active: 2015-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Katie Renee Martin

Introduction: Katie Renee Martin is a prominent inventor based in Rockford, Michigan, with a significant contribution to the field of pharmaceutical innovations. With two patents to her name, she has made strides in the development of compounds aimed at enhancing health and well-being.

Latest Patents: Katie's latest invention focuses on autophagy inhibitors. The present invention relates to compounds of formulas III and V that are useful as pharmaceutical agents, particularly as autophagy inhibitors. This research has the potential to impact how certain diseases are treated, showcasing her ability to merge scientific inquiry with real-world applications.

Career Highlights: Throughout her career, Katie has been associated with well-respected institutions, including the Van Andel Research Institute and the Translational Genomics Research Institute. Her work within these organizations highlights her commitment to advancing medical research and her role in the innovative landscape of healthcare.

Collaborations: Katie has had the opportunity to collaborate with knowledgeable professionals, including Jeffrey Paul MacKeigan and Megan Lynne Goodall. These collaborations have not only enriched her research but have also facilitated the exchange of ideas and expertise in her field.

Conclusion: Katie Renee Martin exemplifies the spirit of innovation with her dedication to research and development in pharmaceutical compounds. Her work and collaborations contribute significantly to the future of medical science, and her inventions promise to make a meaningful difference in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…